Why Did Medpace Holdings Plunge 11.07%?

Medpace Holdings experienced a significant drop of 11.07% in pre-market trading on April 22, 2025, raising concerns among investors about the company's recent performance.

Analysts had anticipated a 3.4% year-on-year increase in Medpace's revenue for the first quarter of 2025, projecting it to reach $528.2 million. However, this growth rate is notably slower compared to the 17.7% increase recorded in the same period the previous year. This deceleration in revenue growth has contributed to the recent decline in the company's stock price.

Additionally, Medpace's shares have been under pressure due to missed expectations in Q2 bookings. The company's performance in this area has fallen short of analyst projections, further impacting investor sentiment and leading to the stock's decline.